Norethindrone Acetate, Ethinyl Estradiol Articles

New Warner Chilcott posts 1st-qtr loss

11 July 2005

Warner Chilcott's low-dose femhrt approved

24 January 2005

UPDATE: Ireland's Warner Chillcott mulls L1.7 billion offer from private equity group

27 September 2004

Warner Chilcott beats expectations

16 August 2004

Galen sees 2nd-qtr 2004 EPS rocket 84%

24 May 2004

Galen reports 105% leap in 1st-qtr sales

16 February 2004

Sales strong at Galen on acquisition spree, organic growth now sought

17 November 2003

Barr Labs and Galen in oral contraceptives licensing deal

22 September 2003

Sales rise on acquisitions at Galen; underlying growth solid in second quarter

18 August 2003

Stock Commentary - Europe

18 August 2003

Galen completes Pfizer product acquisitions

28 April 2003

Galen seeking to buy Pfizer drugs for $359M

10 March 2003

Pfizer and Warner-Lambert merger creates industry's largest R&D budget

10 February 2000

Warner-Lambert's Lipitor And Rezulin Will Fuel Growth

9 September 1998

W-L To Stay Independent As Product Line Improves

30 April 1998

W-L To Stay Independent As Product Line Improves

24 April 1998

Showing 1-16 of 16 articles

Go to beginningPrevious
  • 1
NextGo to end